Gildan’s shares closed Tuesday, June 16, at $70.39, down 18.75 per cent. In one session about $3-billion of market value was gone, leaving the Canadian T-shirt maker worth $13-billion.
The trigger was a 60-page report from Jehoshaphat Research, a Florida-based investment firm that disclosed it was betting against the stock. The size of that bet, it said, equals 4 per cent of the shares open to public trading. The firm’s charge was blunt: “We believe this company has been inflating its revenues through channel stuffing for years but is finally running out of room to do so.”
What the short seller claims
Channel stuffing means pushing more product onto customers than they need so a quarter looks stronger than demand justifies. Jehoshaphat said it spoke with seven former Gildan employees, customers or distributors, without giving their rank or how long they had worked there. According to the report, Gildan asked clients to take in more goods than they might need in a given quarter and sweetened the request by stretching payment periods to 90 days or 120 days.
The practice is hard to see, the report argued, because Gildan sells part of its accounts receivable through factoring. The buyers hand over cash up front, normally at a discount, and take on the job of collecting. That moves the balances off Gildan’s balance sheet.
The company’s answer
Gildan did not concede anything. In a statement the same day it said it was “confident that its current disclosure provides its investors with accurate and comprehensive information.” It also repeated its fiscal 2026 guidance: full-year revenue of US$6-billion to US$6.2-billion and free cash flow above US$850-million. The Globe and Mail, which reported the story, said the company did not return a request for comment.
Jehoshaphat has form in Canada. In September 2025 it accused the subprime lender goeasy Ltd. of sitting on more bad loans than it had disclosed. Months later goeasy announced surging loan losses and suspended its dividend. That stock is down 75 per cent over the past year.
Gildan was already familiar to investors as the centre of a boardroom fight. Directors removed chief executive Glenn Chamandy in December 2023, saying they had lost faith in his leadership. Shareholders pushed back, won a campaign to have the board resign and brought Chamandy back.
Lawyers move in
The plunge brought the plaintiffs’ firms. By mid-October, several law firms had announced a proposed securities class action against Gildan and certain executives, covering investors who bought shares from February 19, 2025, through June 15, 2026. The complaints allege that Gildan lacked adequate internal controls and used excess shipments and extended payment terms to make revenue look better than it was, which made its statements on the business and outlook misleading.
The suit leans on the June 16 research report, which said Gildan had accumulated roughly $500 million in excess product or accelerated sales. Investors have until December 14, 2026, to ask the court to appoint them lead plaintiff. These are allegations only, and no class has been certified.
Sources
- Gildan shares sink 19 per cent on short seller report alleging inflated sales (The Globe and Mail, Tim Kiladze)
- Gildan Faces Class Action Over Alleged Channel Stuffing (IJR)





